Google
NRXS — NEURAXIS, INC. (Healthcare >> Biotechnology)
NRXS FAQ
What is NRXS's ROE?
NEURAXIS, INC. reports a Return on Equity (ROE) of -126.72%.
What is NRXS's dividend yield?
NEURAXIS, INC. offers a dividend yield of 0.00%.
What is NRXS's Deepscope Quality Score?
Deepscope rates NRXS's overall financial quality at 62 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NRXS?
Deepscope's AI Timing Score for NRXS is 67 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NRXS belong to?
NEURAXIS, INC. is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 7.27
Price
0.20
(2.83%)
Day Change
|
|
|---|
NRXS, the overall quality is ok ( Quality = 62) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- NEUTRAL
- Signal Description
- Company financial health is OK
- Reason
-
ROE is relatively low.
ROA is relatively low.
ROA is too relatively low compare to ROE
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 7.27 |
| PBV / Sector |
15.23 / 4.58
|
| Earning Per Share | -0.60 |
| PE / Sector |
N/A / 17.10
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
1.14 M
GREAT
|
| Average 1W Daily Value |
1.22 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
60% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-05 09:12:33 |
| Symbol | NRXS |
| Name | NEURAXIS, INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 12.38 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 87.56 / 8,655.90 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 11611 North Meridian St, Carmel, IN, United States, 46032
Phone: 812 689 0791
Website: https://neuraxis.com
Sector: Healthcare >> Biotechnology
Description: NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
